These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15796961)

  • 1. Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes.
    Mendoza S; David H; Gaylord GM; Miller CW
    Cancer Genet Cytogenet; 2005 Apr; 158(2):142-7. PubMed ID: 15796961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
    Katoh M; Katoh M
    Int J Oncol; 2003 May; 22(5):1155-9. PubMed ID: 12684685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26.
    Katoh M; Katoh M
    Int J Mol Med; 2003 May; 11(5):579-83. PubMed ID: 12684693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome].
    Wada C; Ishigaki M; Toyo-oka Y; Yamabe H; Ohnuki Y; Takada F; Yamazaki Y; Ohtani H
    Rinsho Byori; 1996 May; 44(5):435-8. PubMed ID: 8676562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma.
    Ohata N; Ito S; Yoshida A; Kunisada T; Numoto K; Jitsumori Y; Kanzaki H; Ozaki T; Shimizu K; Ouchida M
    Int J Mol Med; 2006 Dec; 18(6):1153-8. PubMed ID: 17089020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.
    Reardon W; Winter RM; Rutland P; Pulleyn LJ; Jones BM; Malcolm S
    Nat Genet; 1994 Sep; 8(1):98-103. PubMed ID: 7987400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations.
    Ingersoll RG; Paznekas WA; Tran AK; Scott AF; Jiang G; Jabs EW
    Cytogenet Cell Genet; 2001; 94(3-4):121-6. PubMed ID: 11856867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer.
    Ricol D; Cappellen D; El Marjou A; Gil-Diez-de-Medina S; Girault JM; Yoshida T; Ferry G; Tucker G; Poupon MF; Chopin D; Thiery JP; Radvanyi F
    Oncogene; 1999 Dec; 18(51):7234-43. PubMed ID: 10602477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.
    Ueda T; Sasaki H; Kuwahara Y; Nezu M; Shibuya T; Sakamoto H; Ishii H; Yanagihara K; Mafune K; Makuuchi M; Terada M
    Cancer Res; 1999 Dec; 59(24):6080-6. PubMed ID: 10626794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.
    Wilkie AO; Slaney SF; Oldridge M; Poole MD; Ashworth GJ; Hockley AD; Hayward RD; David DJ; Pulleyn LJ; Rutland P
    Nat Genet; 1995 Feb; 9(2):165-72. PubMed ID: 7719344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.
    Jabs EW; Li X; Scott AF; Meyers G; Chen W; Eccles M; Mao JI; Charnas LR; Jackson CE; Jaye M
    Nat Genet; 1994 Nov; 8(3):275-9. PubMed ID: 7874170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization of the human fibroblast growth factor receptor 2 (FGFR2) gene and comparative analysis of the human FGFR gene family.
    Zhang Y; Gorry MC; Post JC; Ehrlich GD
    Gene; 1999 Apr; 230(1):69-79. PubMed ID: 10196476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Crouzon syndrome synonymous mutation activates a 5' splice site within the IIIc exon of the FGFR2 gene.
    Del Gatto F; Breathnach R
    Genomics; 1995 Jun; 27(3):558-9. PubMed ID: 7558045
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.